ALK inhibitor 1

CAS No. 761436-81-1

ALK inhibitor 1( —— )

Catalog No. M26052 CAS No. 761436-81-1

ALK inhibitor 1 is a selective ALK kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 106 In Stock
5MG 177 In Stock
10MG 267 In Stock
25MG 536 In Stock
50MG 762 In Stock
100MG 1017 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ALK inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    ALK inhibitor 1 is a selective ALK kinase inhibitor.
  • Description
    ALK inhibitor 1 is a selective ALK kinase inhibitor.(In Vitro):ALK inhibitor 1 inhibits IGF-1R.
  • In Vitro
    ALK inhibitor 1 (compound 17) inhibits IGF-1R with an IC50 of 90 nM.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    FAK
  • Recptor
    Glucocorticoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    761436-81-1
  • Formula Weight
    562.49
  • Molecular Formula
    C23H28BrN7O3S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?1M HCl : 100 mg/mL (177.78 mM)
  • SMILES
    CNS(=O)(=O)c1ccccc1Nc1nc(Nc2ccc(cc2OC)N2CCN(C)CC2)ncc1Br
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Torres MP, Entwistle F, Coote PJ. Effective immunosuppression with dexamethasone phosphate in the Galleria mellonella larva infection model resulting in enhanced virulence of Escherichia coli and Klebsiella pneumoniae. Med Microbiol Immunol. 2016 Aug;205(4):333-43. doi: 10.1007/s00430-016-0450-5. PubMed PMID: 26920133; PubMed Central PMCID: PMC4939170.
molnova catalog
related products
  • FAK-IN-14

    FAK-IN-14 is a highly effective focal adhesion kinase (FAK) inhibitor that induces apoptosis and cell cycle arrest.

  • Defactinib

    Defactinib (VS-6063, PF-04554878) is a potent, selective and orally active FAK inhibitor, selectively inhibits pFAK (Tyr397) in a dose-dependent manner in cancer cell lines.

  • Batatasin III

    Batatasin III inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition and FAK-AKT signals and possesses anti-cancer activities. Batatasin III has a long-term inhibitory effect on whole-plant growth and shows germination.